Trenbolone acetate is an anabolic steroid with FDA-approved veterinary cattle ear-implant products. It is not an FDA-approved human medicine, and evidence from cattle implants cannot establish safety, product quality or effectiveness for human use.

Insufficient evidence. Review the research and limitations before relying on this record.

FDA animal-drug material identifies trenbolone acetate as a synthetic androgen used in cattle implants. An androgenic mechanism does not supply human clinical evidence or a human safety profile.

The FDA sources describe subcutaneous slow-release pellet implants in the ears of specified cattle. Those delivery systems cannot be used to infer exposure from injectable, oral or other products marketed for people.

No FDA-approved human indication is identified in the sources reviewed. The documented approvals are animal-drug approvals for specified cattle production settings, so they cannot establish human efficacy or safety.

The cited FDA material states that extralabel use of cattle ear implants for growth promotion is illegal. There is no regulator-verified human product label in this record to support a human adverse-effect profile, monitoring plan or product-standard claim. Trenbolone is also within the anabolic-agent class prohibited in sport.

This entry distinguishes documented veterinary use from human use. It is not a protocol or a recommendation. Products promoted for people under this name are not made equivalent by the existence of an animal-drug approval.